From: Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population
Haplotype Event | N° events/at risk | Hazard ratio | P | P BH | |
---|---|---|---|---|---|
Carrier | Non-carrier | ||||
TCTTAT | Â | Â | Â | Â | Â |
 All coronary events | 40/951 | 66/1076 | 0.73 (0.49–1.11) | 0.14 | 0.21 |
 Myocardial infarction | 20 | 33 | 0.77 (0.42–1.41) | 0.40 | 0.56 |
 Coronary revascularisation | 30 | 48 | 0.75 (0.47–1.19) | 0.22 | 0.22 |
 Ischaemic cardiomyopathy | 6 | 16 | 0.56 (0.21–1.51) | 0.25 | 0.25 |
TCTTGT | Â | Â | Â | Â | Â |
 All coronary events | 46/937 | 60/1090 | 0.90 (0.58–1.39) | 0.63 | 0.63 |
 Myocardial infarction | 26 | 27 | 1.19 (0.67–2.11) | 0.56 | 0.56 |
 Coronary revascularisation | 30 | 48 | 0.74 (0.46–1.20) | 0.22 | 0.22 |
 Ischaemic cardiomyopathy | 9 | 13 | 0.59 (0.24–1.43) | 0.24 | 0.25 |
GTCCGC | Â | Â | Â | Â | Â |
 All coronary events | 43/614 | 63/1413 | 1.78 (1.24–2.56) | 0.0018 | 0.0054 |
 Myocardial infarction | 23 | 30 | 1.96 (1.16–3.31) | 0.012 | 0.036 |
 Coronary revascularisation | 33 | 45 | 1.87 (1.20–2.91) | 0.0058 | 0.017 |
 Ischaemic cardiomyopathy | 11 | 11 | 3.16 (1.41–7.09) | 0.0053 | 0.016 |